BL

Bruce Linton

Melodiol Global Health Limited | Non-Executive Director
Mr Linton is a cannabis executive and has sector experience as a founder, CEO, Board member and advisor to a number of global cannabis and psychedelic focused companies. Mr Linton's experience include his role as founder, Chairman and ex-CEO of Canopy Group Corporation. Mr Linton was also responsible for securing market support for 16 funding rounds and progressing over 30 M&A opportunities. He led Canopy Growth through its start-up phase to becoming the first producing cannabis company to list on the New York Stock Exchange. Following his departure from Canopy Growth, he has led direct investments into the cannabis and psychedelic sector while undertaking management and strategic advisory roles. These include being Executive Chairman of Gage Cannabis Co. and a Director of psychedelic medicines company, Mind Medicines Inc.

Company and Role

Company
Title
Tenure
Since
ME1
Melodiol Global Health Limited
  • Non-Executive Director
2yrs, 2mthJan 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ME1
Melodiol Global Health Limited
17/01/248,144,097N/A38,389,417N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ME1
Melodiol Global Health Limited
17/01/24
Expiry
10,000,000$0.001$10,000Options expired
ME1
Melodiol Global Health Limited
16/11/23
Issued
2,732,213$0.003$8,196Director remuneration
ME1
Melodiol Global Health Limited
13/11/23
Issued
657,204$0.002$1,314Prospectus
ME1
Melodiol Global Health Limited
27/10/23
Issued
2,732,213$0.012$33,333Director remuneration
ME1
Melodiol Global Health Limited
27/01/23
Issued
10,000,000$0.022$220,000Director remuneration